Guadalupe Díaz del Castillo-Flores
Research Subjects
Guadalupe Díaz del Castillo-Flores has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Cassandra González-Acosta
Dirección del Programa de Enfermedades Transmitidas por Vector, Centro Nacional de Programas Preventivos y Control de Enfermedades, Secretaría de Salud de México, Mexico City, Mexico
1 shared publication - Eric Saúl Raga-Sarabia
Centro Estatal de Cancerología, Veracruz, Mexico
1 shared publication - Jesús Felipe González-Roldán
Sociedad Mexicana de Salud Pública, Mexico City, Mexico
1 shared publication - Jorge Fernando Méndez-Galván
Hospital Infantil de Mexico Federico Gomez, Mexico City, Mexico
1 shared publication - Julio Alvarez-Obregón
Takeda Mexico, Mexico City, Mexico
1 shared publication - Victoria Pando-Robles
Centro de Investigaciones Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México
1 shared publication
Latest Publications
- Open Access
- 3 December 2025
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 113 (6) , 1363-1374
Epidemiological and Economic Burden of Dengue in Mexico: Data Analysis from 2010 to 2020
: Dengue is the most prevalent arboviral disease worldwide. This study aimed to describe the epidemiological and economic burden of dengue in Mexico by identifying comorbidities and conditions associated with clinical outcomes. A retrospective analysis of dengue epidemiological data in Mexico from 2010 to 2020 was conducted using surveillance system databases (Sistema Nacional de Vigilancia Epidemiológica and Sistema Único de Información para la Vigilancia Epidemiológica). Data on probable, laboratory-confirmed, outpatient, and hospitalized cases as well as deaths were collected along with comorbidities and pregnancy status; a survey was conducted to gather information on health care resources utilization. Sistema Nacional de Vigilancia Epidemiológica recorded 1,620,872 cases, among which there were 336,991 laboratory-confirmed cases, 110,437 hospitalizations, and 1,385 deaths. The hospitalization fatality rate increased from 0.72% to 2.6%. Age distribution of severe dengue shifted from predominantly affecting individuals 10–24 years old (2010–2016) to those 0–19 years old (2017–2020). These findings highlight the need for age-specific health care interventions. Comorbidities, such as diabetes, liver cirrhosis, hypertension, kidney disease, and hematological disorders, and pregnancy were significantly associated with an increased risk of hospitalization and mortality. Additionally, peptic ulcer was associated with a higher risk of hospitalization. The estimated annual medical cost during outbreak was U.S. $111,851,376 (2019, 211.0 [case] incidence) in contrast to pre-/postoutbreak, with total costs of U.S. $23,713,589 (2018, 62.4 [case] incidence) and U.S. $39,780,809 (2020, 94.1 [case] incidence), respectively. The robustness of collected data contributes to more comprehensive understanding of the public health implications of dengue, particularly during outbreaks.
- 3 December 2025
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 113 (6) , 1363-1374
Open AccessEpidemiological and Economic Burden of Dengue in Mexico: Data Analysis from 2010 to 2020
: Dengue is the most prevalent arboviral disease worldwide. This study aimed to describe the epidemiological and economic burden of dengue in Mexico by identifying comorbidities and conditions associated with clinical outcomes. A retrospective analysis of dengue epidemiological data in Mexico from 2010 to 2020 was conducted using surveillance system databases (Sistema Nacional de Vigilancia Epidemiológica and Sistema Único de Información para la Vigilancia Epidemiológica). Data on probable, laboratory-confirmed, outpatient, and hospitalized cases as well as deaths were collected along with comorbidities and pregnancy status; a survey was conducted to gather information on health care resources utilization. Sistema Nacional de Vigilancia Epidemiológica recorded 1,620,872 cases, among which there were 336,991 laboratory-confirmed cases, 110,437 hospitalizations, and 1,385 deaths. The hospitalization fatality rate increased from 0.72% to 2.6%. Age distribution of severe dengue shifted from predominantly affecting individuals 10–24 years old (2010–2016) to those 0–19 years old (2017–2020). These findings highlight the need for age-specific health care interventions. Comorbidities, such as diabetes, liver cirrhosis, hypertension, kidney disease, and hematological disorders, and pregnancy were significantly associated with an increased risk of hospitalization and mortality. Additionally, peptic ulcer was associated with a higher risk of hospitalization. The estimated annual medical cost during outbreak was U.S. $111,851,376 (2019, 211.0 [case] incidence) in contrast to pre-/postoutbreak, with total costs of U.S. $23,713,589 (2018, 62.4 [case] incidence) and U.S. $39,780,809 (2020, 94.1 [case] incidence), respectively. The robustness of collected data contributes to more comprehensive understanding of the public health implications of dengue, particularly during outbreaks.